These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6745863)

  • 1. Disposition and metabolism of metronidazole in patients with liver failure.
    Farrell G; Baird-Lambert J; Cvejic M; Buchanan N
    Hepatology; 1984; 4(4):722-6. PubMed ID: 6745863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronidazole: pharmacokinetic observations in severely ill patients.
    Ljungberg B; Nilsson-Ehle I; Ursing B
    J Antimicrob Chemother; 1984 Sep; 14(3):275-83. PubMed ID: 6490572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of metronidazole in patients with varying degrees of renal failure.
    Houghton GW; Dennis MJ; Gabriel R
    Br J Clin Pharmacol; 1985 Feb; 19(2):203-9. PubMed ID: 3986078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dose and route of administration on disposition of metronidazole and its major metabolites.
    Loft S; Døssing M; Poulsen HE; Sonne J; Olesen KL; Simonsen K; Andreasen PB
    Eur J Clin Pharmacol; 1986; 30(4):467-73. PubMed ID: 3743624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of metronidazole and its metabolites in reduced renal function.
    Bergan T; Thorsteinsson SB
    Chemotherapy; 1986; 32(4):305-18. PubMed ID: 3731917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronidazole pharmacokinetics in patients with hepatic encephalopathy.
    Loft S; Sonne J; Døssing M; Andreasen PB
    Scand J Gastroenterol; 1987 Jan; 22(1):117-23. PubMed ID: 3563404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
    Lamp KC; Freeman CD; Klutman NE; Lacy MK
    Clin Pharmacokinet; 1999 May; 36(5):353-73. PubMed ID: 10384859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronidazole pharmacokinetics in patients with acute renal failure.
    Somogyi AA; Kong CB; Gurr FW; Sabto J; Spicer WJ; McLean AJ
    J Antimicrob Chemother; 1984 Feb; 13(2):183-9. PubMed ID: 6706889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.
    Lau AH; Lam NP; Piscitelli SC; Wilkes L; Danziger LH
    Clin Pharmacokinet; 1992 Nov; 23(5):328-64. PubMed ID: 1478003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic activity of metronidazole in plasma and urine of volunteers with normal or impaired renal function.
    Turgeon PL; Dufresne LR; Ogilvie RI; Kreeft JH
    Surgery; 1983 Jan; 93(1 Pt 2):154-7. PubMed ID: 6849200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition and removal of metronidazole in patients undergoing haemodialysis.
    Somogyi A; Kong C; Sabto J; Gurr FW; Spicer WJ; McLean AJ
    Eur J Clin Pharmacol; 1983; 25(5):683-7. PubMed ID: 6662167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronidazole elimination is preserved in the elderly.
    Loft S; Egsmose C; Sonne J; Poulsen HE; Døssing M; Andreasen PB
    Hum Exp Toxicol; 1990 May; 9(3):155-9. PubMed ID: 2375881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of metronidazole and its metabolites in critically ill patients.
    Plaisance KI; Quintiliani R; Nightingale CH
    J Antimicrob Chemother; 1988 Feb; 21(2):195-200. PubMed ID: 3360682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronidazole kinetics in dialysis patients.
    Kreeft JH; Ogilvie RI; Dufresne LR
    Surgery; 1983 Jan; 93(1 Pt 2):149-53. PubMed ID: 6849199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis.
    Daneshmend TK; Homeida M; Kaye CM; Elamin AA; Roberts CJ
    Gut; 1982 Oct; 23(10):807-13. PubMed ID: 7117899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of omeprazole on the pharmacokinetics of metronidazole and hydroxymetronidazole in human plasma, saliva and gastric juice.
    Jessa MJ; Goddard AF; Barrett DA; Shaw PN; Spiller RC
    Br J Clin Pharmacol; 1997 Sep; 44(3):245-53. PubMed ID: 9296318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
    Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
    Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma hydroxy-metronidazole/metronidazole ratio in patients with liver disease and in healthy volunteers.
    Muscará MN; Pedrazzoli J; Miranda EL; Ferraz JG; Hofstätter E; Leite G; Magalhães AF; Leonardi S; De Nucci G
    Br J Clin Pharmacol; 1995 Nov; 40(5):477-80. PubMed ID: 8703652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of metronidazole metabolism by human liver microsomes.
    Loft S; Otton SV; Lennard MS; Tucker GT; Poulsen HE
    Biochem Pharmacol; 1991 Apr; 41(8):1127-34. PubMed ID: 2009091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.
    Morgan DJ; McLean AJ
    Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.